{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:57:03Z","timestamp":1790751423768,"version":"4.1.0"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>p21-activated kinase 1 (Pak1) is a serine\/threonine kinase implicated in cardioprotection, calcium handling, and excitation-contraction coupling. However, the effects of Pak1 gain- and loss-of-function on cardiac performance remain incompletely understood. Here, we characterized baseline overall cardiac performance in cardiac-specific Pak1 transgenic (TG) and knockout (KO) mice using advanced echocardiography and invasive hemodynamic assessments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Adult wild type (WT), Pak1 TG, and Pak1 KO mice, aged 7\u201311 months, underwent comprehensive phenotyping, including M-mode echocardiography, pulsed-wave and tissue Doppler imaging, speckle-tracking echocardiography (STE)-based strain analysis, invasive left ventricular pressure measurements, Western blot analysis, and histological evaluation using hematoxylin and eosin and Masson's trichrome staining. In addition, WT and Pak1 TG mice aged 20\u201322 months were studied to assess persistence of the TG phenotype with aging.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      M-mode echocardiography showed that Pak1 TG mice exhibited concentric LV remodeling, characterized by increased wall thickness and reduced chamber dimensions compared with KO and WT controls. Histological analysis revealed greater cardiomyocyte cross-sectional area and width in TG mice than in KO mice, whereas WT values were intermediate and did not differ significantly from TG. Masson's trichrome staining detected no significant difference in myocardial fibrosis between TG and WT hearts under the present sampling conditions. Atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) expression was not elevated in TG hearts. TG hearts exhibited higher fractional shortening and increased global longitudinal, radial, and circumferential strain, indicating increased echocardiographic indices of systolic function. Invasive hemodynamics showed higher +\n                      <jats:italic>dP<\/jats:italic>\n                      \/\n                      <jats:italic>dt<\/jats:italic>\n                      <jats:sub>max<\/jats:sub>\n                      without a significant difference in aortic blood pressure, although these findings do not establish load-independent intrinsic contractility. Diastolic indices also differed, including increased diastolic strain rates, shorter IVRT, lower Tau, and reduced myocardial performance index, whereas\n                      <jats:italic>E<\/jats:italic>\n                      \/\n                      <jats:italic>e<\/jats:italic>\n                      \u2032 was unchanged. Similar remodeling and functional indices were observed in aged TG mice, although the cross-sectional design does not establish preservation with aging. Pak1 KO mice showed modestly reduced systolic indices with preserved diastolic indices.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Pak1 overexpression is associated with concentric LV remodeling and favorable systolic and diastolic functional indices. These findings support further investigation of Pak1-dependent mechanisms and its role in cardiac disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1858786","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:06:09Z","timestamp":1790748369000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Pak1 overexpression is associated with mild concentric cardiac remodeling and favorable systolic and diastolic functional indices in transgenic mice"],"prefix":"10.3389","volume":"13","author":[{"given":"Johnathan","family":"Yarbro","sequence":"first","affiliation":[{"name":"Department of Biomedical Sciences, New York Institute of Technology, College of Osteopathic Medicine","place":["Old Westbury, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamayo","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, New York Institute of Technology, College of Osteopathic Medicine","place":["Old Westbury, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youhua","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, New York Institute of Technology, College of Osteopathic Medicine","place":["Old Westbury, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Levy","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, New York Institute of Technology, College of Osteopathic Medicine","place":["Old Westbury, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, New York Institute of Technology, College of Osteopathic Medicine","place":["Old Westbury, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, New York Institute of Technology, College of Osteopathic Medicine","place":["Old Westbury, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiangrong","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, New York Institute of Technology, College of Osteopathic Medicine","place":["Old Westbury, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"e275","DOI":"10.1161\/CIR.0000000000001412","article-title":"2026 heart disease and stroke statistics: a report of US and global data from the American Heart Association","volume":"153","author":"Palaniappan","year":"2026","journal-title":"Circulation"},{"key":"B2","doi-asserted-by":"publisher","first-page":"100826","DOI":"10.1016\/j.jmccpl.2025.100826","article-title":"Cardiomyocyte Rac1 signaling in hypertrophy, arrhythmia, and cardiac stress adaptation","volume":"14","author":"Teuber","year":"2025","journal-title":"J Mol Cell Cardiol Plus"},{"key":"B3","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.yjmcc.2011.09.016","article-title":"Ablation of p21-activated kinase-1 in mice promotes isoproterenol-induced cardiac hypertrophy in association with activation of Erk1\/2 and inhibition of protein phosphatase 2A","volume":"51","author":"Taglieri","year":"2011","journal-title":"J Mol Cell Cardiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1161\/CIRCULATIONAHA.111.048785","article-title":"Pak1 as a novel therapeutic target for antihypertrophic treatment in the heart","volume":"124","author":"Liu","year":"2011","journal-title":"Circulation"},{"key":"B5","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1161\/CIRCHEARTFAILURE.112.000123","article-title":"A novel immunomodulator, FTY-720 reverses existing cardiac hypertrophy and fibrosis from pressure overload by targeting NFAT (nuclear factor of activated T-cells) signaling and periostin, circulation","volume":"6","author":"Liu","year":"2013","journal-title":"Heart Fail"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e101974","DOI":"10.1371\/journal.pone.0101974","article-title":"Inhibition of angiotensin II-induced cardiac hypertrophy and associated ventricular arrhythmias by a p21 activated kinase 1 bioactive peptide","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"B7","doi-asserted-by":"publisher","first-page":"H224","DOI":"10.1152\/ajpheart.00612.2011","article-title":"p21-activated kinase improves cardiac contractility during ischemia-reperfusion concomitant with changes in troponin-T and myosin light chain 2 phosphorylation","volume":"302","author":"Monasky","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1007\/s11010-020-03993-3","article-title":"Deletion of P21-activated kinase-1 induces age-dependent increased visceral adiposity and cardiac dysfunction in female mice","volume":"476","author":"Batra","year":"2021","journal-title":"Mol Cell Biochem"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e70006","DOI":"10.1002\/cph4.70006","article-title":"Solaro, p21-activated kinase 1 (Pak1) as an element in functional and dysfunctional interplay among the myocardium, adipose tissue, and pancreatic beta cells","volume":"15","author":"Rosas","year":"2025","journal-title":"Compr Physiol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1161\/CIRCEP.113.001198","article-title":"Pak1 is required to maintain ventricular ca(2)(+) homeostasis and electrophysiological stability through SERCA2a regulation in mice","volume":"7","author":"Wang","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"20220285","DOI":"10.1098\/rstb.2022.0285","article-title":"Targeting p21-activated kinase 1 for development of a novel anti-arrhythmic drug class","volume":"378","author":"He","year":"2023","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"B12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.yjmcc.2013.04.014","article-title":"Functional integrity of the T-tubular system in cardiomyocytes depends on p21-activated kinase 1","volume":"60","author":"DeSantiago","year":"2013","journal-title":"J Mol Cell Cardiol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"C47","DOI":"10.1152\/ajpcell.00012.2008","article-title":"Expression of active p21-activated kinase-1 induces Ca2+ flux modification with altered regulatory protein phosphorylation in cardiac myocytes","volume":"296","author":"Sheehan","year":"2009","journal-title":"Am J Physiol Cell Physiol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1093\/cvr\/cvv234","article-title":"Knockout of p21-activated kinase-1 attenuates exercise-induced cardiac remodelling through altered calcineurin signalling","volume":"108","author":"Davis","year":"2015","journal-title":"Cardiovasc Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":"3444","DOI":"10.1016\/j.cell.2026.03.008","article-title":"Rational discovery of therapeutic PAK1 allosteric activators","volume":"189","author":"He","year":"2026","journal-title":"Cell"},{"key":"B16","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.yjmcc.2017.10.006","article-title":"Echocardiographic evaluation of diastolic function in mouse models of heart disease","volume":"114","author":"Schnelle","year":"2018","journal-title":"J Mol Cell Cardiol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s11886-023-01844-3","article-title":"Echo Doppler parameters of diastolic function","volume":"25","author":"Anthony","year":"2023","journal-title":"Curr Cardiol Rep"},{"key":"B18","doi-asserted-by":"publisher","first-page":"12344","DOI":"10.1038\/s41598-023-39499-3","article-title":"Myocardial deformation imaging by 2D speckle tracking echocardiography for assessment of diastolic dysfunction in murine cardiopathology","volume":"13","author":"Daniels","year":"2023","journal-title":"Sci Rep"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e0149155","DOI":"10.1371\/journal.pone.0149155","article-title":"Speckle tracking based strain analysis is sensitive for early detection of pathological cardiac hypertrophy","volume":"11","author":"An","year":"2016","journal-title":"PLoS One"},{"key":"B20","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/gerona\/gly139","article-title":"Echocardiographic strain analysis for the early detection of left ventricular systolic\/diastolic dysfunction and dyssynchrony in a mouse model of physiological aging","volume":"74","author":"De Lucia","year":"2019","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"B21","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1161\/CIRCRESAHA.110.239574","article-title":"Echocardiographic speckle-tracking based strain imaging for rapid cardiovascular phenotyping in mice","volume":"108","author":"Bauer","year":"2011","journal-title":"Circ Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1182\/blood-2008-06-160861","article-title":"p21-activated kinase regulates mast cell degranulation via effects on calcium mobilization and cytoskeletal dynamics","volume":"113","author":"Allen","year":"2009","journal-title":"Blood"},{"key":"B23","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/cvr\/cvaa110","article-title":"Towards standardization of echocardiography for the evaluation of left ventricular function in adult rodents: a position paper of the ESC working group on myocardial function","volume":"117","author":"Zacchigna","year":"2021","journal-title":"Cardiovasc Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.pharmthera.2010.04.005","article-title":"Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies","volume":"128","author":"Bernardo","year":"2010","journal-title":"Pharmacol Ther"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1657950","DOI":"10.3389\/fcvm.2025.1657950","article-title":"Regulatory mechanisms of exercise-induced physiological cardiac hypertrophy: progress and prospects","volume":"12","author":"Cheng","year":"2025","journal-title":"Front Cardiovasc Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1016\/j.jcmg.2019.01.044","article-title":"2- And 3-dimensional myocardial strain in cardiac health and disease","volume":"12","author":"Voigt","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1111\/bph.13872","article-title":"The p21-activated kinase 1 (Pak1) signalling pathway in cardiac disease: from mechanistic study to therapeutic exploration","volume":"175","author":"Wang","year":"2018","journal-title":"Br J Pharmacol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"H1487","DOI":"10.1152\/ajpheart.01003.2010","article-title":"Activation of Pak1\/akt\/eNOS signaling following sphingosine-1-phosphate release as part of a mechanism protecting cardiomyocytes against ischemic cell injury","volume":"301","author":"Egom","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"79","DOI":"10.53941\/ijddp.2023.100006","article-title":"p21-activated kinases present a new drug target for hypertrophic cardiomyopathy","volume":"2","author":"He","year":"2023","journal-title":"Int J Drug Discov Pharmacol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1093\/ejhf\/xuag023","article-title":"Effect of the cardiac myosin activator omecamtiv mecarbil on ventricular arrhythmias, cardiac arrest, and sudden death in heart failure with reduced ejection fraction: the GALACTIC-HF trial","volume":"28","author":"Foa","year":"2026","journal-title":"Eur J Heart Fail"},{"key":"B31","doi-asserted-by":"crossref","first-page":"e76964","DOI":"10.1002\/advs.76964","article-title":"A novel Pak1 activator ameliorates ER stress for HFpEF therapy","author":"Xu","year":"2026","journal-title":"Adv Sci (Weinh)"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1858786\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:06:10Z","timestamp":1790748370000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1858786\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":31,"alternative-id":["10.3389\/fcvm.2026.1858786"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1858786","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"article-number":"1858786"}}